Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TTSH | Common Stock | Tax liability | -$34.4K | -4.4K | -4.25% | $7.82 | 99K | Oct 23, 2021 | Direct | F1, F2, F3 |
holding | TTSH | Common Stock | 820 | Oct 23, 2021 | By Child #1 | ||||||
holding | TTSH | Common Stock | 775 | Oct 23, 2021 | By Child #2 | ||||||
holding | TTSH | Common Stock | 765 | Oct 23, 2021 | By Child #3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | TTSH | Stock Option (Right to Buy) | 2.74K | Oct 23, 2021 | Common Stock | 2.74K | $14.19 | Direct | F4 | |||||
holding | TTSH | Stock Option (Right to Buy) | 5.4K | Oct 23, 2021 | Common Stock | 5.4K | $8.50 | Direct | F5 |
Id | Content |
---|---|
F1 | The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Issuer to withhold shares otherwise issuable upon vesting of the previously reported grant. |
F2 | Includes (i) 3,195 shares of restricted stock for which the risks of forfeiture will lapse as to 1,597 shares on 2/20/22 and 1,598 shares on 2/20/23; (ii) 28,736 shares of restricted stock for which the risks of forfeiture will lapse as to 14,368 shares on each of 10/23/22 and 10/23/23; (iii) 10,685 shares of restricted stock for which the risks of forfeiture will lapse as to 3,562 shares on each of 3/16/22 and 3/16/23 and 3,561 shares on 3/16/24; (iv) 7,607 shares of restricted stock for which the risks of forfeiture will lapse as to 2,535 shares on 3/15/22 and 2,536 shares on each of 3/15/23 and 3/15/24; and |
F3 | (v) 15,214 shares of performance-based restricted stock for which the risks of forfeiture will lapse in three installments of 4,564, 4,564 and 6,086 on each of the dates that the Issuer files its annual report for the years ending December 31, 2021, 2022 and 2023, respectively, subject to Mr. Davis remaining in continuous employment with the Issuer prior to and as of December 31 of the year preceding the applicable vesting date and the Issuer achieving its performance target for each respective year. |
F4 | Fully exercisable. |
F5 | Options to purchase 1,350 shares will vest on 11/6/2021. |